Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ospemifene Dose Ranging for Vulvar and Vaginal Atrophy
NCT00630539Phase 2Completed
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Aug 2007
- Primary completion
- Jan 2008
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of ospemifene in vulvovaginal atrophy (VVA), sponsored by Shionogi & Co., Ltd.. Started Aug 2007; status: completed.
02
Drugs
ospemifene
03
Conditions
vulvovaginal atrophy (VVA)
Beyond the preview
Go deeper on NCT00630539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00630539.